Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06809335 · ClinicalTrials.gov registry record · NA
A Pilot of a Personalized Circadian mHealth to Improve Sleep in Night Shift Workers
A NA study of Shift Work Sleep Disorder, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06809335: Recruiting NA study of Shift Work Sleep Disorder, sponsored by Henry Ford Health System.
NCT06809335 is a NA study of Shift Work Sleep Disorder that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06809335, a NA study of Shift Work Sleep Disorder, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to establish the evidence base for equitable accessibility and implementation of the precision sleep medicine mobile application, SHIFT.
Primary Outcome
Aim 1a. Measure the effect of SHIFT on work productivity and satisfaction compared to waitlist control using the Job Satisfaction Index. Effect will be tested using a mixed-effects linear regression model with participants as the random effect and Time, Condition, and the Time × Condition interaction term as the fixed effects. Aim 1b: Measure the effect of SHIFT on global health compared to waitlist control using the NIH PROMIS Global Health questionnaire. Effect will be tested using the same m
Conditions Studied
Interventions
- OTHER Personalized circadian mHealth
Study Locations (1)
Michigan
- Henry Ford Columbus Medical Center - Novi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-10-23 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06809335 shows while recruiting
NCT06809335 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Shift Work Sleep Disorder appearing as the primary indexed condition, and to 1 intervention - of which Personalized circadian mHealth is the first listed.
NCT06809335 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06809335 about?
NCT06809335 is a clinical study titled "A Pilot of a Personalized Circadian mHealth to Improve Sleep in Night Shift Workers". The goal of this project is to establish the evidence base for equitable accessibility and implementation of the precision sleep medicine mobile application, SHIFT.
What is the current status of trial NCT06809335?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-10-23. Estimated completion is 2027-06.
What conditions does trial NCT06809335 study?
This clinical trial studies the following conditions: Shift Work Sleep Disorder.
What interventions are being tested in trial NCT06809335?
The interventions under investigation include: Personalized circadian mHealth (OTHER).
Who is sponsoring clinical trial NCT06809335?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06809335 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06809335's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI